Martin Hendrix serves as Executive at Prometheus Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Martin Hendrix has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 16, 2023 involved selling 2,071 shares valued at $0.
Martin Hendrix currently holds 2,071 shares of Prometheus Biosciences, Inc. (RXDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin Hendrix has been a net neutral trader of RXDX stock. They have purchased $0 and sold $0 worth of shares.
Martin Hendrix's most recent insider trade was on Jun 16, 2023, when they sold 2,071 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |